CME Group Inc. (NASDAQ:CME) Shares Acquired by Frank Rimerman Advisors LLC

Frank Rimerman Advisors LLC raised its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 143,821.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,149 shares of the financial services provider’s stock after buying an additional 20,135 shares during the period. Frank Rimerman Advisors LLC’s holdings in CME Group were worth $3,961,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Gold Investment Management Ltd. acquired a new stake in shares of CME Group in the fourth quarter valued at about $26,000. Salomon & Ludwin LLC acquired a new stake in CME Group in the first quarter valued at approximately $28,000. Y.D. More Investments Ltd purchased a new stake in shares of CME Group during the second quarter valued at approximately $36,000. Rise Advisors LLC acquired a new position in shares of CME Group during the first quarter worth $41,000. Finally, McClarren Financial Advisors Inc. boosted its stake in shares of CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Barclays lifted their price target on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. JPMorgan Chase & Co. boosted their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Deutsche Bank Aktiengesellschaft increased their price target on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th. Piper Sandler restated an “overweight” rating and set a $225.00 price objective on shares of CME Group in a report on Tuesday, August 20th. Finally, Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and reduced their target price for the company from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Four research analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus target price of $209.73.

View Our Latest Stock Report on CME

CME Group Price Performance

Shares of NASDAQ CME opened at $213.16 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $76.75 billion, a price-to-earnings ratio of 24.25, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $223.80. The business has a 50 day simple moving average of $207.86 and a 200-day simple moving average of $207.45.

CME Group (NASDAQ:CMEGet Free Report) last released its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the previous year, the firm earned $2.30 earnings per share. The firm’s revenue for the quarter was up 12.7% compared to the same quarter last year. As a group, equities research analysts expect that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.16%. CME Group’s dividend payout ratio (DPR) is 52.33%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.